BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6796342)

  • 1. Intrathecal chemotherapy for leptomeningeal dissemination of medulloblastoma.
    Edwards MS; Levin VA; Seager ML; Wilson CB
    Childs Brain; 1981; 8(6):444-51. PubMed ID: 6796342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal chemotherapy with antineoplastic agents in children.
    Ruggiero A; Conter V; Milani M; Biagi E; Lazzareschi I; Sparano P; Riccardi R
    Paediatr Drugs; 2001; 3(4):237-46. PubMed ID: 11354696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination.
    Slavc I; Schuller E; Czech T; Hainfellner JA; Seidl R; Dieckmann K
    J Neurooncol; 1998; 38(2-3):213-8. PubMed ID: 9696374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of leptomeningeal metastasis in solid tumors.
    Mack F; Baumert BG; Schäfer N; Hattingen E; Scheffler B; Herrlinger U; Glas M
    Cancer Treat Rev; 2016 Feb; 43():83-91. PubMed ID: 26827696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
    Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal chemotherapy delivered by a lumbar-thecal catheter in metastatic medulloblastoma: a case illustration.
    Clayton J; Vloeberghs M; Jaspan T; Walker D; MacArthur D; Grundy R
    Acta Neurochir (Wien); 2008 Jul; 150(7):709-12. PubMed ID: 18401539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival in a child with extraneural metastasis from medulloblastoma treated with chemo-radiotherapy.
    Paulino AC
    Med Pediatr Oncol; 2003 Jun; 40(6):396-7. PubMed ID: 12692812
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrathecal liposomal cytarabine and leptomeningeal medulloblastoma relapse: a valuable therapeutic option.
    Mastronuzzi A; Del Bufalo F; Iacono A; Secco DE; Serra A; Colafati GS; DE Ioris MA; Corsetti T
    Anticancer Res; 2013 Aug; 33(8):3515-8. PubMed ID: 23898128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
    Chamberlain MC; Kormanik PA; Barba D
    J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer.
    Tran HC; Gardner S; Weiner HL; Liebes LF; Finlay JL
    J Oncol Pharm Pract; 2014 Jun; 20(3):229-32. PubMed ID: 23929729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supratentorial leptomeningeal metastasis of a medulloblastoma without cerebellar tumor recurrence.
    Gerlach R; Kieslich M; van de Nes J; Galow W; Seifert V
    Acta Neurochir (Wien); 2002 Feb; 144(2):201-4; discussion 204. PubMed ID: 11862522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of leptomeningeal malignancy.
    Pentheroudakis G; Pavlidis N
    Expert Opin Pharmacother; 2005 Jun; 6(7):1115-25. PubMed ID: 15957966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal thiotepa: reappraisal of an established therapy.
    Fisher PG; Kadan-Lottick NS; Korones DN
    J Pediatr Hematol Oncol; 2002 May; 24(4):274-8. PubMed ID: 11972095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
    Kochi M; Kuratsu J; Mihara Y; Takaki S; Seto H; Uemura S; Ushio Y
    Neurosurgery; 1993 Nov; 33(5):817-23. PubMed ID: 8264878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.
    Nygaard R; Kivivuori SM
    Anticancer Drugs; 2012 Mar; 23(3):342-6. PubMed ID: 22156796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptomeningeal lymphoma: perspectives on management.
    Lokich J; Galbo C
    Cancer Treat Rev; 1981 Jun; 8(2):103-10. PubMed ID: 6788373
    [No Abstract]   [Full Text] [Related]  

  • 18. Intrathecal methotrexate affects cognitive function in children with medulloblastoma.
    Riva D; Giorgi C; Nichelli F; Bulgheroni S; Massimino M; Cefalo G; Gandola L; Giannotta M; Bagnasco I; Saletti V; Pantaleoni C
    Neurology; 2002 Jul; 59(1):48-53. PubMed ID: 12105306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durable Response of Leptomeningeal Metastasis of Breast Cancer to Salvage Intrathecal Etoposide After Methotrexate: A Case Report and Literature Review.
    Park MJ
    Am J Case Rep; 2015 Aug; 16():524-7. PubMed ID: 26258900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of patients with meningeal carcinomatosis.
    Nakagawa H; Murasawa A; Kubo S; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    J Neurooncol; 1992 May; 13(1):81-9. PubMed ID: 1613540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.